key: cord-0293052-xoywl6ux
authors: Anzalone, A. J.; Horswell, R.; Hendricks, B.; Chu, S.; Hillegass, W.; Beasley, W.; Harper, J.; Rosen, C.; Miele, L.; McClay, J.; Santangelo, S.; Hodder, S.; Consortium, N3C
title: Higher Hospitalization and Mortality Rates Among SARS-CoV-2 infected Persons in Rural America
date: 2021-10-07
journal: nan
DOI: 10.1101/2021.10.05.21264543
sha: 3cf677a06526ce8ec6bc3217064abcee02993c4b
doc_id: 293052
cord_uid: xoywl6ux

IMPORTANCE: Rural communities are among the most underserved and resource-scarce populations in the United States (US), yet there are limited data on COVID-19 mortality in rural America. Furthermore, rural data are rarely centralized, precluding comparability across urban and rural regions. OBJECTIVE: The purpose of this study is to assess hospitalization rates and all-cause inpatient mortality among persons with definitive COVID-19 diagnoses residing in rural and urban areas. DESIGN, SETTINGS, AND PARTICIPANTS: This retrospective cohort study from the National COVID Cohort Collaborative (N3C) examines a cohort of 573,018 patients from 27 US hospital systems presenting with SARS-CoV-2 infection between January 2020 and March 2021, of whom 117,897 were hospitalized. A sample of 450,725 hospitalized persons without COVID-19 diagnoses was identified for comparison. EXPOSURES: ZIP Codes provided by source hospital systems were classified by urban-rural gradient through a crosswalk to the US Department of Agriculture Rural-Urban Commuting Area Codes. MAIN OUTCOMES AND MEASURES: Primary outcomes were hospitalization and all-cause mortality among hospitalized patients. Kaplan-Meier analysis and mixed effects logistic regression were used to estimate 30-day survival in hospitalized patients and associations between rurality, hospitalization, and inpatient mortality while controlling for major risk factors. RESULTS: Rural patients were more likely to be older, white, have higher body mass index, and diagnosed with SARS-CoV-2 later in the pandemic compared with their urban counterparts. Rural compared with urban inhabitants had higher rates of hospitalization (23% vs. 19%) and all-cause mortality among hospitalized patients (16% vs. 11%). After adjustment for demographic and baseline differences, rural residents (both urban adjacent and non-adjacent) with COVID-19 were more likely to be hospitalized (Adjusted Odds Ratio (AOR) 1.41, 95% Confidence Interval (CI), 1.37-1.45 and AOR 1.42, CI 1.35-1.50) and to die or be transferred to hospice (AOR 1.62, CI 1.30-1.49 and 1.38, CI 1.30-1.49), respectively. Similar differences in mortality were noted for hospitalized patients without SARS-CoV-2 infection. CONCLUSIONS: Hospitalization and inpatient mortality are higher among rural compared with urban persons with COVID-19, even after adjusting for several factors, including age and comorbidities. Further research is needed to understand the factors that drive health disparities in rural populations.

The novel coronavirus (SARS-CoV-2) was the third leading cause of death in the United States 82 (US) in 2020 1 and is responsible for more than 650,000 deaths to date. 2 During the initial four months 83 of the US SARS-CoV-2 epidemic, cases were most concentrated in urban areas. However, by late 84 2020, rural communities experienced a surge in SARS-CoV-2 infections with some of the highest 85 case rates in the nation. 3 Nonmetropolitan areas constitute 97% of the US land area, with 86 approximately 20% of the population residing in rural areas. 4 Rural compared with urban inhabitants 87 are older, less likely to engage in behaviors to prevent SARS-CoV-2 infection, 5 and have a higher 88 prevalence of comorbidities (e.g., obesity) associated with more severe COVID-19 (C19) and death. 6 

They have also experienced a greater disparity in over life expectancy over the last fifty years, 7 which 90 is likely linked to reduction rural providers 8 and services that necessitate an increase in transfers to 91 distant acute care facilities. 9 Rural residents also face various social, economic, and environmental 92 factors distinct from urban communities. 10 

To better understand potential drivers of C19 outcomes in rural America, we assessed 94 hospitalization and mortality using the National COVID Cohort Collaborative (N3C), a National 95

Institutes of Health-supported data enclave containing electronic health record information on more 96 than 6 million persons tested for SARS-CoV-2 across 55 US sites and more than 2 million patients 97 with a definitive diagnosis of SARS-CoV-2 infection. To our knowledge, this is the largest cohort of 98 C19 cases in North America using data at the patient-level. Previous large-scale studies have been 99 restricted to single states 11 or utilized public health reporting systems. 12 While the relationship 100 between rural and urban hospitalization and mortality has been studied for chronic conditions, limited 101 research has evaluated SARS-CoV-2 infected rural-urban discrepancies. 102

Methods

This retrospective cohort study received Institutional Review Board approval from each 104

investigator's institution and was reviewed and approved by the N3C Data Access Committee. Our 105 . CC-BY-NC-ND 4.0 International license It is made available under a 5 study cohort includes patients diagnosed between January 1, 2020, and March 31, 2021, and a 106 demographically matched (2:1 SARS-CoV-2 uninfected-to-infected matching done at the site level as 107 part of the N3C ingestion process based on age, gender, race, and ethnicity) 13 comparison group of 108 SARS-CoV-2 uninfected persons. This study followed the Enhancing the Quality and Transparency of 109

Health Research (EQUATOR) reporting guidelines, Reporting of Studies Conducted Using 110

Observational Routinely Collected Health Data (RECORD). 14 

N3C Data Enclave 112 N3C has broad inclusion criteria, harmonizing data from 55 sites across the US. 15 N3C collects 113

longitudinal Electronic Health Record (EHR) or Health Information Exchange (HIE) data (with a 2-year 114 "lookback" period to January 1, 2018) on all patients with a C19 diagnostic code (22% of all patients) 115

or a positive SARS-CoV-2 polymerase chain reaction (PCR) or antigen test (78% of all patients) as 116

well as uninfected patients serving as controls. Source system C19 testing protocols are mapped to 117 standard terminologies for labs (LOINC) and conditions (ICD-10 CM and SNOMED CT) by the N3C 118

Data Ingestion and Harmonization Workstream, which maintains a computable phenotype for defining 119 presence of C19. 16 To capture patients during the early stages of the pandemic (before 5/1/2020), 120 patients with two weak diagnostic codes (such as ICD10 J80* Acute Respiratory Distress Syndrome 121 and R43.0 Anosmia) probabilistic of C19 are also included. 17 

Cohort Identification 123

Rural and urban categories were identified by 5-digit ZIP Codes that were then mapped to the 124 2010 Rural-Urban Continuum Codes (RUCA), distinguishing by population density, degree of 125 urbanization, and adjacency to metropolitan areas. 18 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 7, 2021. ;

7 N3C provides patient ZIP Codes for most patients (~66% of all subjects). The majority of 156 missing ZIP Code information is from specific data providers who elect not to provide 5-digit ZIP 157

Codes in their data transmissions. We relied on a RUCA Codes crosswalk to match ZIP Codes and 158

RUCA classifications based on data availability. 30 Charlson Comorbidity Index (CCI) 33 composite score (a higher score indicating worse health), 174 comorbidity categories, tobacco usage, hospitalization, and death/discharge to hospice. Mixed-effects 175 logistic regression models were calculated for the entire C19 and hospitalized C19 groups. Both 176 models included fixed effects for gender, race, ethnicity, BMI, age at visit start, CCI score, and rural 177 category, with an outcome of all-cause inpatient mortality, and random effects for data partner. 178

We assessed model specification using a methodology that checked for specification change 179

influence on the estimate rural versus urban effect. Among the possible specification changes 180 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 7, 2021. was the need to include the data provider organization as a fixed or random effect, with the choice of 186 effect type (fixed versus random) found to be irrelevant. As a result, the initial model was modified to 187 include data providing organization as a random effect. This helps mitigate the possibility that our final 188 model's estimated rural effects are artifacts of mortality differences across those organizations' 189 patient populations.

The risk adjustment process employed in our modeling used information about pre-COVID 191

comorbidities. As patient data in N3C differ in availability of pre-COVID clinical data, ranging from 192 none to two years of pre-COVID clinical data, we examined the possibility that estimated rural effects 193 stemmed from rural and urban patients differing in extent of pre-COVID comorbidity information.

The variables associated with worse outcomes in the logistic model -rurality, Charlson 195

Comorbidity Index, age, and period of SARS-CoV-2 diagnosis -were secondarily evaluated using 196

Kaplan-Meier estimates of the overall time to death, starting from hospital admission, censored at 30 197 days. 198 Results

Our final cohort included data from 27 data partners ( Figure 1) Among all patients, rural populations had higher rates of comorbidities across 14 of the 15 208 comorbidity categories (Appendix C) and had notably higher rates of obesity (Table. 1). We also noted 209 that among our C19 cohorts, between 65% and 80% of patients in each category had prior visit 210 history and between 63% and 74% had prior conditions reported in the pre-COVID period (Figure 1 ), 211

suggesting that our data robustness matrix sufficiently captured patients with high-fidelity data. 212

Assessing date of hospitalization, as a proxy for changes in clinical practice and treatment, we 213

found that rural C19 patients were more likely to be diagnosed, and subsequently hospitalized later in 214 the pandemic (Appendix C) when treatment practices were leading to better outcomes. Urban 215 dwellers had higher caseloads in quarter 2 (17% urban, 10% UAR, 10% NAR; p<0.001) and quarter 3 216

(18% urban, 16% UAR, 15% NAR; p<0.001) of 2020. Urban patients also had higher hospitalization 217 rates in quarter 2 (24% urban, 14% UAR, 16% NAR; p<0.001), but more rural patients were 218 hospitalized in quarter 3 (15% urban, 19% UAR, 18% NAR; p<0.001).

Hospitalization 220

Persons in rural areas were more likely to be hospitalized, UAR ( (Figure 3 .B).

Mortality 226

The model estimates of all-cause inpatient mortality or transfer to hospice after C19 diagnosis 227

were significantly greater for rural compared to urban patients, ( (Figure 3 .D). 232

Kaplan Meier survival curves demonstrate significantly higher mortality 30 days after 233 hospitalization among rural C19 patients compared to their urban counterparts. (Figure 4 .A).

Hospitalized C19 patients with more comorbidities, older age, and diagnosis earlier in the pandemic 235 demonstrated significantly higher mortality (Figure 4 . ventilation and oxygen support were also significantly more frequent among rural than among urban 257 patients (Table 1) . However, the mean time to death was similar ranging between 12-14 days after 258 C19 diagnosis among those hospitalized. Urban patients were more likely to be readmitted to the 259 hospital at any point after initial hospitalization in both the infected and uninfected cohorts. 260 Discussion

In this retrospective cohort study from a large representative data base of both C19 positive 262

and negative patients, we found significantly higher mortality rates among hospitalized rural C19 263

patients. Mortality was approximately 40% higher among rural C19 patients after adjustment for age, 264

gender, race, ethnicity, BMI, Charlson Comorbidity Index composite score, date of diagnosis, and 265

differences derived from the data contributor. 266

The SARS-CoV-2 pandemic provides an important lens to examine all-cause mortality by area 267 of residence. SARS-CoV-2 is a new virus, rapidly transmitted in an immunologically naïve human 268 population and initially without known effective treatment. The rapidity with which first urban then 269 rural communities in the US experienced surges of SARS-CoV-2, led us to hypothesize that an 270 urban-rural mortality differential would not be observed. That, however, is not the case. Although 271 rural populations are older and have higher rates of comorbidities, 34 including diabetes mellitus and 272 obesity 35 which have been associated with increased disease severity and death in SARS-CoV-2 273

infection, adjustment for these factors did not change the finding of higher rural mortality. Notably, 274 mortality among hospitalized patients without C19 diagnoses, after adjustment for several factors, 275

was also significantly higher in rural compared to urban areas, a finding consistent with previous 276 studies. 36,37 277 The gradient of risk for chronic diseases and mortality between urban and rural inhabitants is a 278 relatively recent development in the United States. Prior to 1980, mortality rates in rural and urban 279 . CC-BY-NC-ND 4.0 International license It is made available under a 12 areas of the US were comparable. Since then, mortality rates in rural America have exceeded urban 280 rates, and the gap has accelerated since 1999, even when adjusted for age. 38, 34, 35 This mortality 281 disparity has been referred to as "the nonmetropolitan penalty," 39, and some experts believe that 282 structural urbanism is widening the gap. 40 Similar findings are noted among nonmetropolitan 283 counties for common causes of death, including heart disease, cancer, chronic lower respiratory 284 disease, unintentional injury, and stroke. 6 

Given the modeling objectives, it would be illogical to adjust the rural versus urban comparison 286

for clinical severity, such as clinical severity at the time of hospital admission. If a rural versus urban 287 effect exists, it almost certainly would lead to rural versus urban differences in clinical severity at 288

admission. Therefore, adjusting for clinical severity at admission would result in adjusting away the 289 effect which the modeling seeks to evaluate. Our modeling showed that the rural versus urban effect 290

was larger among patients hospitalized for COVID than among patients hospitalized for non-COVID 291

reasons. This suggests that rurality played a greater relative role in COVID outcomes than it plays in 292 the outcomes resulting from most other (non-COVID) hospitalizations.

The etiology of this "penalty" is likely multi-factorial. Poverty, unemployment, and lower levels 294

of educational attainment are more prevalent in rural areas, and these factors may partially explain 295 the urban-rural mortality disparity. Diminished access to care has also been described as contributing 296

to rural-urban mortality differences. One study concluded that having one or more specialist visits 297 during the previous year was associated with 16.6% lower mortality for those with chronic 298

conditions. 39,41 Among counties with defined shortages in primary care delivery, 56% are 299 nonmetropolitan while 19% are metropolitan, according to data reported by the Health Resources and 300

Services Administration. 42 

Although limited research has been done on socioeconomic risk factors and case-fatality rates 302

over the first year of the SARS-Cov-2 pandemic, a recent study from Japan observed higher C19-303 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint 13 related mortality in prefectures with the lowest household incomes. 43 A recent study conducted using 304 spatial models in the US found rurality to be one of several ecologic determinants of C19 mortality. 44 

Our results again raise the question of why rural populations experience higher mortality rates 306

after adjustment for multiple factors, even with a new pathogen such as SARS-CoV-2. To what extent 307 delays in care contribute to increased SARS-CoV-2 related mortality among rural populations is 308 unclear as is the potential impact of environmental risk factors in rural areas. The increase in 309 hospitalization and hospitalized mortality in our uninfected cohort demonstrates systemic 310 discrepancies in rural-urban outcomes in tertiary care centers that are likely exacerbated by C19. 311

Identifying and understanding potential causes of urban-rural health disparities including 312 mortality across both chronic and acute conditions may inform study of rational and cost-effective 313 mitigation strategies. Others 45, 46, 47 have demonstrated that attribution of rurality does not provide a 314

one-size-fits-all means to prescribe approaches to reduce health disparities. There are many other 315 possible contributors to the observed disparity, highlighting the urgent need for a robust research 316 agenda that will address the root causes which may differ by geographic region. 317

While confirming worse baseline health status and outcomes of rural dwellers from chronic 318 conditions, the N3C data also suggest rural dwellers have incremental vulnerability to C19 as an 319

acute health condition. The disparately adverse C19 acute outcomes among rural dwellers do not 320 appear to be fully explained by the worse baseline health measures. The C19 pandemic appears to 321 both highlight and extend the apparent relative vulnerability of rural dwellers to acute health 322

conditions. Recent scholarship points to a dynamic, ecological model for addressing rural adversity 323 based on tailored approaches to individual community needs. 48 Additional observational and 324 experimental research is needed to potentially identify practical evidence-based steps to improve 325 health outcomes among rural dwellers for both acute and chronic health conditions. 326

Limitations 327

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ;

N3C is an observational registry compiling data from multiple diverse participating sites. Therefore, 328 some information may be entirely or partially and non-randomly missing from the database in rural 329 versus urban residents. In our C19 positive cohort, we report incidence of comorbidities in more than 330

two-thirds of our study population, which is similar to those reported in a COVID-19 study across 331

OCHIN, a network of 396 community health centers across 14 states. 49 Nonetheless, we examined 332 the possibility that estimated rural effects stemmed from rural and urban patients differing in extent of 333

pre-COVID comorbidity information and found this not to be the case. To some degree, such potential 334 bias can be partly assessed by future analyses, which would include data based on all diagnosed 335 C19+ populations in geographic areas, rather than data limited to C19 patients who received care at 336 N3C collaborating provider systems. 50 A second potential confounder is that rural residents with C19 337 may have been diagnosed later in their disease course than urban residents, leading to a greater risk 338 of serious complications. Additionally, healthcare organizations contributing data to N3C may have 339 cared for more severely ill patients, providing a potential source of bias. 340

Other limitations of the N3C data source include data aggregated from different health systems 341

with different local practices, regulations, and data models, resulting in potential reporting differences, 342 despite our application of data robustness checks. Additionally, the comparison group is limited only 343

to those pre-matched at the site level from patients who have had a confirmed negative SARS-CoV-2 344

test. Although 54% of American Indian and Alaska Native populations in the US live in rural areas and 345 have been disproportionately affected by Covid19, 51,52 their racial demographic is unavailable for 346 explicit study in accordance with tribal sovereignty policies. Finally, these analyses are limited to 347 residents in the US and may not be generalizable to other countries. 348

Conclusions 349

Hospitalization and death were significantly more frequent among rural C19 patients than their 350 urban counterparts after adjusting for multiple factors, including age, sex, race, and comorbidities. An 351 analysis of adjusted mortality among hospitalized SARS-CoV-2 uninfected patients demonstrated 352 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint similar results. These data provide evidence-based documentation of rural health disparities. Further 353

research is needed to understand this disparity for both acute and chronic health conditions. 354

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint 3 Censored to remove small cell count or potential reidentification of small cell count . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint Figure 1 : Data Analysis Plan Figure 1 documents the data analysis plan, including steps for inclusion and exclusion of data partners based on availability of ZIP Codes, whether they pre-shifted dates by over 45 days, and robustness based on covariates of interest (measurement domain to calculate BMI and death domain for primary outcome). Our Data Robustness Matrix includes determining fact counts in each domain of interest (death, measurement) and excluding sites who were one standard deviation below the mean reporting percentage in our initial cohort.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint Figure 2 shows the geospatial distribution of the N3C COVID-19 positive population. N3C contains data from 55 data contributors from across the United States, 40 of whom include sufficient location information to spatially map by ZIP Code centroid. Of those sites, we selected 27 whose data met our minimum robustness qualifications for inclusion in our study. This bubble map is to scale with larger bubbles representing more patients. Figure 2 .A. shows all N3C patients. Figure 2 .B. shows only urban N3C distribution. Figure 2 .C. shows urban-adjacent rural patient distribution. Figure 2 .D. shows nonurban-adjacent rural patient distribution, which represents the most isolated patients in N3C.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. Figure 3 shows the unadjusted odds and adjusted ratios for being hospitalized (A and B) and dying or being transferred to hospice after hospitalization for the COVID-19 infected population (C and D) and uninfected population (E and F) in N3C. Risk is similar between adjusted and unadjusted models, suggesting a real impact of rurality on hospitalization and all-cause mortality. Adjusted models include adjustments for gender, race, ethnicity, BMI, age, Charlson Comorbidity Index (CCI) composite score, rurality, and quarter of diagnosis. Data provider is included as a random effect in all models to account for differences across source data systems. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ;

Appendix C: Quarter of Diagnosis, COVID-19 therapies, BMI Categories, Age Group, and Appendix C shows differences in key areas by rurality category, including quarter of diagnosis (A) therapy exposure (B), BMI category (C) age group (D) and comorbidity incidence (E). Overall, common risk factors associated with poorer outcomes are present in the urban-adjacent and nonurban-adjacent rural cohorts (A, C, D, E), but the same cohorts receive similar treatment (B).

24% . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 7, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.05.21264543 doi: medRxiv preprint

Provisional Mortality Data-United States, 2020. Morbidity and Mortality Weekly Report

An interactive web-based dashboard to track COVID-19 in real time

COVID-19 Stats: COVID-19 Incidence, by Urban-Rural Classification -United States

Rural and Urban Differences in COVID-19 Prevention Behaviors

Trends in Meeting Physical Activity Guidelines Among Urban and Rural Dwelling Adults -United States

Widening rural-urban disparities in life expectancy

Retention of primary care physicians in rural health professional shortage areas

The Importance of Rural Hospitals: Transfers and 30-day Readmissions Among Rural Residents and Patients Presenting at Rural Hospitals

Community Susceptibility and Resiliency to COVID-19 Across the Rural-Urban Continuum in the United States

The synchronicity of COVID-19 disparities: Statewide epidemiologic trends in SARS-CoV-2 morbidity, hospitalization, and mortality among racial minorities and in rural America

Determinants of COVID-19 Case Fatality Rate in the United States: Spatial Analysis Over One Year of the Pandemic

COVID-19 Phenotype Documentation, Version 3.3. N3C Phenotype & Data Acquisition Workstream

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

N3C Phenotype & Data Acquisition Workstream. Github Repository

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

Rural-Urban Commuting Area Codes

Assessment of Rural-Urban Differences in Health Care Use and Survival Among Medicare Beneficiaries with Alzheimer Disease and Related Dementia

Concordance of Rural-Urban Self-identity and ZIP Code-Derived Rural-Urban Commuting Area (RUCA) Designation

Small rural hospitals and high-risk operations: how would regionalization affect surgical volume and hospital revenue?

Comparison of COVID-19 case and death counts in the United States reported by four online trackers

Extending an open-source tool to measure data quality: case report on Observational Health Data Science and Informatics (OHDSI)

Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network

Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations

Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data

Rural Health Domain Team

United States

ZIP Code File

HRSA Federal Office of Rural Health Policy. Defining rural population

Reproducible Summary Tables with the gtsummary Package

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries

Differences in health-related quality of life in rural and urban veterans

Diabetes care and outcomes; disparities across rural America

Association Between Income Inequality and County-Level COVID-19 Cases and Deaths in the US

Nonmetropolitan COVID-19 Incidence and Mortality Rates Surpassed Metropolitan Rates Within the First 24 Weeks of the Pandemic Declaration: United States

Rural-Urban Disparity in Mortality in the US From

Preliminary evidence for an emerging nonmetropolitan mortality penalty in the United States

Structural Urbanism Contributes to Poorer Health Outcomes for Rural America

Widening rural-urban disparities in all-cause mortality and mortality from major causes of death in the USA

Data downloads: Health Professional Shortage Areas (HPSAs), HPSA-Primary Care

Association of Socioeconomic Characteristics with Disparities in COVID-19 Outcomes in Japan

Determinants of COVID-19 Case Fatality Rate in the United States: Spatial Analysis Over One Year of the Pandemic

A Closer Look at Rural-Urban Health Disparities: Associations Between Obesity and Rurality Vary by Geospatial and Sociodemographic Factors

Factors Impacting Patient Outcomes Associated with Use of Emergency Medical Services Operating in Urban Versus Rural Areas: A Systematic Review

Lack Of Access to Specialists Associated with Mortality and Preventable Hospitalizations Of Rural Medicare Beneficiaries

What Is Rural Adversity, How Does It Affect Wellbeing and What Are the Implications for Action?

Prevalence of Pre-existing Conditions Among Community Health Center Patients With COVID-19: Implications for the Patient Protection and Affordable Care Act

Lack of Access to Specialists Associated with Mortality and Preventable Hospitalizations of Rural Medicare Beneficiaries

Twice Invisible: Understanding Rural Native America. Longmont, CO: First Nations Development Institute

American Indians and Alaska Natives in the COVID-19 Pandemic: The Grave Burden We Stand to Bear

COVID-19 Vaccinations in the United States, County. Centers for Disease Control and Prevention